Inactive Instrument
Zalicus Inc Stock Nasdaq
Stocks
US98887C1053
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 746K 665K 616K 560K 1.05M 70.75M 1.07M 7.39M 2.91M 36.98M 2.8M 2.74M 118M | P/E 2014 |
-0.83x | P/E 2015 | -1.35x |
|---|---|---|---|---|---|
| Enterprise Value | -15.94M -14.21M -13.16M -11.96M -22.45M -1.51B -22.82M -158M -62.06M -790M -59.79M -58.54M -2.52B | EV / Sales 2014 |
14,770,294,750x | EV / Sales 2015 | 83,658,631x |
| Free-Float |
100% | Yield 2014 * |
-
| Yield 2015 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.52% | -7.19% | +51.66% | +69.99% | 65.83B | |
| +0.08% | +8.05% | +10.67% | +83.84% | 51.87B | |
| +2.08% | +3.67% | +2.05% | +64.35% | 51.2B | |
| -0.38% | +1.40% | +29.98% | +42.37% | 43.76B | |
| +0.30% | +5.64% | +16.99% | +133.30% | 42.09B | |
| +2.35% | -6.08% | +236.69% | +528.10% | 39.04B | |
| +2.16% | +9.87% | +18.92% | +59.70% | 34B | |
| +3.84% | -2.34% | +39.18% | +8.57% | 25.2B | |
| +0.51% | +3.48% | +28.67% | +23.84% | 22.8B | |
| Average | +1.38% | +0.27% | +48.31% | +112.67% | 41.76B | |
| Weighted average by Cap. | +1.28% | +0.20% | +46.86% | +114.75% |
| 2014 | 2015 | |
|---|---|---|
| Net sales | 0 0 0 0 0.01 0.38 0.01 0.04 0.02 0.2 0.02 0.01 0.63 | 0.7 0.62 0.58 0.53 0.99 66.46 1 6.94 2.73 34.74 2.63 2.58 111.04 |
| Net income | -41.84M -37.3M -34.55M -31.42M -58.95M -3.97B -59.92M -414M -163M -2.07B -157M -154M -6.63B | -52.19M -46.52M -43.09M -39.18M -73.52M -4.95B -74.73M -517M -203M -2.59B -196M -192M -8.27B |
| Net Debt | -14.18M -12.64M -11.71M -10.65M -19.98M -1.34B -20.31M -140M -55.23M -703M -53.2M -52.09M -2.25B | -16.68M -14.87M -13.77M -12.52M -23.5M -1.58B -23.89M -165M -64.97M -827M -62.59M -61.28M -2.64B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
